Reston, VA (PRWEB) July 10, 2013
Join iCONECT Development LLC, technology leaders who reach beyond the status quo with an intuitive and flexible document review platform that works the way you think, for ?ePocalypse Now: The 24/7 Work Week, Social Media and The Cloud” on Wednesday, July 17th at 1:00pm EDT. Hosted by Thomas Barnett, Esq., noted eDiscovery expert, this educational webinar will examine how technology is changing our communication, our work and, really, our lives, tracking almost everything we say and do. Tweeting, texting, IMing, and Facebooking aren?t simply forms of communication; they create potential evidence. This thundercloud of comingled personal and work data, on mixed-use devices and often third-party controlled, is COMING SOON to a litigation near you. Are you ready?
Reserve My Free Webinar Seat Now
The amount of data in the world is exploding at an unprecedented rate, creating a tidal wave of potentially discoverable information. Attorneys, legal professionals and their clients must not only understand the wave of data heading their way but what can be done to avoid being overwhelmed. Join us on July 17th as we examine relevant issues, including the following:
(PRWEB) June 29, 2013
Illinois CancerCare, P.C. is one of only seven community oncology practices in the country recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) for improving cancer care through high-quality clinical trials programs. In 2012, Illinois CancerCare, P.C. enrolled over 300 patients in clinical trials, giving them the opportunity to receive cutting-edge cancer therapies. Illinois CancerCare, P.C. currently has around 100 ongoing clinical trials in over 28 different cancer types, including breast, lung, colon and leukemia. Illinois CancerCare, P.C. is one of only a few community oncology practices in the country to receive this award twice.
?As physicians, our number one goal is to provide our patients with the best possible care available. In 2012, almost 10% of our patients participated in cancer clinical trials,? said Sachdev P. Thomas, MD, Physician Director of Clinical Research and Pharmacy Services. Illinois CancerCare is honored to have been chosen for this award.?
The Conquer Cancer Foundation of ASCO Clinical Trials Participation Award (CTPA) was established in 2003 by ASCO as part of the Clinical Trials Task Force?s strategic plan to increase clinical trial awareness and participation by physicians. The award was designed to recognize and promote high-quality clinical research sites in order to further the impact of oncology research and has been supported by the Coalition of Cancer Cooperative Groups through the Conquer Cancer Foundation for 11 consecutive years.
?The Conquer Cancer Foundation and ASCO are pleased to honor Illinois CancerCare, P.C. with the Clinical Trials Participation Award for providing patients with access to high-quality clinical research that contributes towards progress against cancer,? said W. Charles Penley, MD, FASCO, Chair of the Conquer Cancer Foundation Board of Directors.
This year?s award recipients were selected based on several factors, including patient accrual to clinical trials. Special consideration was given to practices that increased clinical trial participation among underrepresented populations, as well as practices that use innovative techniques to overcome barriers to the enrollment of cancer patients in clinical trials. Clinical research staff at Illinois CancerCare spend additional time with patients interested in learning more about participation in a cancer clinical trial as they continue the consent process usually begun by the physician-investigators. As a means to expand this process outside of Peoria, video conferencing using Skype is made available at the Ottawa and Bloomington clinic sites for staff to interact with patients about potential studies.
Additionally, iPads are utilized by patients during their office/treatment visits to gather important information to better identify cancer care disparities and optimize cancer care delivery. The Research Department partnered with the Illinois CancerCare Foundation to develop the Clinical Trials Advocacy Program to educate the community about the importance of clinical trials and to debunk myths and misconceptions.
In addition to being a community leader in providing patients access to clinical trials, Illinois CancerCare, P.C. also offers patients cancer care and treatment from a compassionate, skilled, and dedicated professional staff. Illinois CancerCare, P.C. also provides patients and their families access to nutritional, counseling, and psychosocial support services.
For more information on participating in a clinical trial at Illinois CancerCare, P.C. contact Jamie Harper, Clinical Research Manager at 309.243.3618 or jharper(at)illinoiscancercare(dot)com. For a complete list of available clinical trials, visit http://www.illinoiscancercare.com.
About Illinois CancerCare:
Illinois CancerCare is one of the largest practices in the state of Illinois that treats patients with cancer and blood diseases. It provides state of the art treatments to its patients against these complex diseases by staying at the leading edge of clinical research. Illinois CancerCare is central Illinois? largest network of cancer care specialists with 90-120 open clinical cancer research trials being conducted at any given time. The group has been recognized by the Quality Oncology Practice Initiative (QOPI